The complementarity of DDR, nucleic acids and anti-tumour immunity

AVR Kornepati, CM Rogers, P Sung, TJ Curiel - Nature, 2023 - nature.com
Immune checkpoint blockade (ICB) immunotherapy is a first-line treatment for selected
cancers, yet the mechanisms of its efficacy remain incompletely understood. Furthermore …

[PDF][PDF] The complementarity of DDR, nucleic acids and anti-tumour immunity

AVR Kornepati, CM Rogers, P Sung, TJ Curiel - Nature, 2023 - bookcafe.yuntsg.com
Immune checkpoint blockade (ICB) immunotherapy is a first-line treatment for selected
cancers, yet the mechanisms of its efficacy remain incompletely understood. Furthermore …

The complementarity of DDR, nucleic acids and anti-tumour immunity

AVR Kornepati, CM Rogers, P Sung, TJ Curiel - Nature, 2023 - scholars.uthscsa.edu
Immune checkpoint blockade (ICB) immunotherapy is a first-line treatment for selected
cancers, yet the mechanisms of its efficacy remain incompletely understood. Furthermore …

The complementarity of DDR, nucleic acids and anti-tumour immunity

AVR Kornepati, CM Rogers, P Sung, TJ Curiel - Nature, 2023 - ui.adsabs.harvard.edu
Immune checkpoint blockade (ICB) immunotherapy is a first-line treatment for selected
cancers, yet the mechanisms of its efficacy remain incompletely understood. Furthermore …

The complementarity of DDR, nucleic acids and anti-tumour immunity

AVR Kornepati, CM Rogers, P Sung, TJ Curiel - Nature, 2023 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint blockade (ICB) immunotherapy is a first-line treatment for selected
cancers, yet the mechanisms of its efficacy remain incompletely understood. Furthermore …

The complementarity of DDR, nucleic acids and anti-tumour immunity

AVR Kornepati, CM Rogers, P Sung, TJ Curiel - Nature, 2023 - ideas.repec.org
Immune checkpoint blockade (ICB) immunotherapy is a first-line treatment for selected
cancers, yet the mechanisms of its efficacy remain incompletely understood. Furthermore …

The complementarity of DDR, nucleic acids and anti-tumour immunity

AVR Kornepati, CM Rogers, P Sung, TJ Curiel - Nature, 2023 - econpapers.repec.org
Immune checkpoint blockade (ICB) immunotherapy is a first-line treatment for selected
cancers, yet the mechanisms of its efficacy remain incompletely understood. Furthermore …